Skip to main content
SpringerLink
Log in

Cost-effective options for preventing relapse in depression?

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Klein NS, et al. Cost-effectiveness, cost-utility and the budget impact of antidepressants versus preventive cognitive therapy with or without tapering of antidepressants. BJPsych open : 15 Jan 2019. Available from: URL: https://doi.org/10.1192/bjo.2018.81

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cost-effective options for preventing relapse in depression?. PharmacoEcon Outcomes News 823, 11 (2019). https://doi.org/10.1007/s40274-019-5701-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-5701-4

Search

Navigation